http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053842-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_172892bc60bf47f6b394f51d33a17149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e5adc0dbc8f4ad2e30edc36f169bb57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0239a6ed5ccaa17f3536204ec16793c
publicationDate 2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009053842-A3
titleOfInvention Prevention of recurrence of urethral stricture after a conventional treatment
abstract Prevention of recurrence of urethral stricture after a conventional treatment. Composition applicable to the prevention of recurrence of urethral stricture after a conventional treatment, including a pharmaceutically effective amount of halofuginone. Urethral stricture, a common disease, appears secondary to urethritis, urethral infection, urethral inflammation, urethral instrumentation, urethral catheterization, urethral trauma, urethral surgery and all types of urethral lesions. Conventional treatments by internal urethrotomy, urethral dilation or surgical urethroplasty are available and can cure urethral stricture, but with a relatively high rate of recurrence of the stricture. Halofuginone can prevent the recurrence of urethral stricture after a conventional treatment via internal urethrotomy, urethral dilation or surgical urethroplasty.
priorityDate 2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006293351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3320124-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5449678-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID400772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136215813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413642

Total number of triples: 24.